Terms: = Uterine cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Prognosis
25 results:
1. [
Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
[TBL] [Abstract] [Full Text] [Related]
2. First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic cancers Using
Loft M; Christensen C; Clausen MM; Carlsen EA; Hansen CP; Kroman N; Langer SW; Høgdall C; Madsen J; Gillings N; Nielsen CH; Klausen TL; Holm S; Loft A; Berthelsen AK; Kjaer A
J Nucl Med; 2022 Dec; 63(12):1871-1879. PubMed ID: 35589407
[TBL] [Abstract] [Full Text] [Related]
3. The Healthcare Journey of Women With Advanced Gynecological cancer From Diagnosis Through Terminal Illness: Qualitative Analysis of Progress Note Data.
Dillon EC; Chopra V; Mesghina E; Milki A; Chan A; Reddy R; Kapp DS; Silver BA; Chan JK
Am J Hosp Palliat Care; 2022 Sep; 39(9):1090-1097. PubMed ID: 34951820
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological Analysis of Neuroendocrine Carcinoma of the uterine Cervix: A Single-Institution Retrospective Review of 9 Cases.
Sağnıç S; Birge Ö; Bakır MS; Karadag C; Şimşek T
Int J Surg Oncol; 2021; 2021():8290659. PubMed ID: 34567803
[TBL] [Abstract] [Full Text] [Related]
5. Whole-tumor histogram analysis of apparent diffusion coefficient for differentiating adenosquamous carcinoma and adenocarcinoma from squamous cell carcinoma in patients with cervical cancer.
Xiao M; Ma X; Ma F; Li Y; Zhang G; Qiang J
Acta Radiol; 2022 Oct; 63(10):1415-1424. PubMed ID: 34382429
[TBL] [Abstract] [Full Text] [Related]
6. Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
Qin F; Pang H; Ma J; Zhao M; Jiang X; Tong R; Yu T; Luo Y; Dong Y
Eur J Radiol; 2021 Aug; 141():109787. PubMed ID: 34051683
[TBL] [Abstract] [Full Text] [Related]
7. Standardized Uptake Value Illuminates Tumor Inflammation and Treatment Response.
Williamson CW; Zamarin D; Mayadev J
Clin Cancer Res; 2021 Aug; 27(15):4136-4138. PubMed ID: 34016640
[TBL] [Abstract] [Full Text] [Related]
8. Volumetric PET parameters are predictive for the prognosis of locally advanced cervical cancer.
Budak A; Budak E; Kanmaz AG; Inan AH; Tosun G; Beyan E; Aldemir OS; Ileri A
Q J Nucl Med Mol Imaging; 2023 Mar; 67(1):69-74. PubMed ID: 33686848
[TBL] [Abstract] [Full Text] [Related]
9. Association of pretreatment SUV
Shou H; Yasuo Y; Yuan S; Lou H; Ni J
Int J Gynaecol Obstet; 2021 Jan; 152(1):112-117. PubMed ID: 33141954
[TBL] [Abstract] [Full Text] [Related]
10. PET Parameters are Useful in Predicting Endometrial cancer Risk Classes and prognosis.
Budak A; Beyan E; Inan AH; Kanmaz AG; Aldemir OS; Oral A; Yazici B; Akgün A; Ozeren M
Nuklearmedizin; 2021 Feb; 60(1):16-24. PubMed ID: 33105511
[TBL] [Abstract] [Full Text] [Related]
11. The value of the apparent diffusion coefficient in differentiating type II from type I endometrial carcinoma.
Chen J; Fan W; Gu H; Wang Y; Liu Y; Chen X; Ren S; Wang Z
Acta Radiol; 2021 Jul; 62(7):959-965. PubMed ID: 32727213
[TBL] [Abstract] [Full Text] [Related]
12. FDG PET correlates weakly with HIF-1
Surov A; Schmidt SA; Prasad V; Beer AJ; Wienke A
Acta Radiol; 2021 Apr; 62(4):557-564. PubMed ID: 32551804
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of semiquantitative metabolic parameters of the primary tumor obtained in PET/CT with 18F-FDG and 18F-FLT in patients with cervical cancer.
Cegła P; Burchardt E; Cholewiński W; Gwóźdź S; Roszak A; Kubiak A; Kaczmarek A; Czepczyński R
Nuklearmedizin; 2020 Jun; 59(3):241-247. PubMed ID: 32097971
[TBL] [Abstract] [Full Text] [Related]
14. Value of Intratumoral Metabolic Heterogeneity and Quantitative
Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM
AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078
[No Abstract] [Full Text] [Related]
15. Pulmonary and mediastinum metastasis of uterine leiomyoma: A case report.
Huang L; Shi G; Wang Q; Guo Y; Cong M
Medicine (Baltimore); 2019 Dec; 98(49):e18276. PubMed ID: 31804368
[TBL] [Abstract] [Full Text] [Related]
16. Strain elastography as an early predictor of long-term prognosis in patients with locally advanced cervical cancers treated with concurrent chemoradiotherapy.
Xu Y; Zhu L; Zhu L; Wang H; Ru T; Liu B; He J; Tian S; Zhou Z; Yang X
Eur Radiol; 2020 Jan; 30(1):471-481. PubMed ID: 31359126
[TBL] [Abstract] [Full Text] [Related]
17. Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical cancer Are Associated with prognosis.
Carpenter DJ; Jacobs CD; Wong TZ; Craciunescu O; Chino JP
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):356-366. PubMed ID: 31254659
[TBL] [Abstract] [Full Text] [Related]
18. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
Akin S; Dizdar O; Karakas Y; Turker A; Kars A
Curr Probl Cancer; 2018; 42(3):344-349. PubMed ID: 29576383
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
20. Evaluation of short- and long-term efficacy of chemoradiotherapy for advanced cervical cancer using HSP70 protein combined with multimodal MRI.
Qi YX; Liu K; Yin J; Li L
J Cell Biochem; 2018 Apr; 119(4):3017-3029. PubMed ID: 29023986
[TBL] [Abstract] [Full Text] [Related]
[Next]